20 May 2013
Keywords: fda, accepts, sanofi, snda, eloxatin, food, drug
Article | 03 March 2008
The US Food and Drug Administration has accepted for filing and assigned
priority review status to a supplemental New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2008
© 2013 thepharmaletter.com